This inventor holds 1 USPTO granted patent. Top assignee: Powerject Vaccines Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Innovations in Genetic Vaccination by Joel R. Haynes
Introduction
Joel R. Haynes is an accomplished inventor based in Fort Collins, Colorado. He has made significant contributions to the field of genetic vaccination, particularly in the development of methodologies aimed at inducing anti-viral immune responses. His work is pivotal in advancing vaccine technology and enhancing public health.
Latest Patents
Haynes holds a patent for a groundbreaking invention titled "Genetic induction of anti-viral immune response and genetic vaccine for filovirus." This patent describes an innovative approach to genetic vaccine methodology. The invention involves transfecting a genetic construction encoding antigenic determinants of a filovirus into the cells of vaccinated individuals. This process utilizes a particle acceleration protocol to express viral antigens in healthy cells, thereby eliciting a robust immune response to those antigens. He has 1 patent to his name.
Career Highlights
Throughout his career, Joel R. Haynes has been associated with Powerject Vaccines Inc., a company dedicated to advancing vaccine technologies. His expertise in genetic vaccination methodologies has positioned him as a key figure in the field. His work has the potential to revolutionize how vaccines are developed and administered.
Collaborations
Haynes has collaborated with notable scientists in the field, including Connie S. Schmaljohn and Deborah L. Fuller. These collaborations have further enriched his research and contributed to the advancement of vaccine technology.
Conclusion
Joel R. Haynes is a prominent inventor whose work in genetic vaccination is paving the way for innovative solutions to combat viral infections. His contributions are vital to the ongoing efforts in public health and vaccine development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile